Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2024	Jun. 25, 2023	Jun. 26, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income		$ 3,827,772	$ 4,510,931	$ 4,605,286
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		359,699	342,432	333,739
Deferred income taxes		(198,981)	(172,061)	(257,438)
Equity-based compensation expense		293,058	286,600	259,064
Other, net		10,243	52,298	(44,751)
Changes in operating asset and liability accounts:
Accounts receivable, net of allowance		303,443	1,452,256	(1,287,680)
Inventories		528,723	(961,968)	(1,351,344)
Prepaid expenses and other assets		(15,535)	136,016	(53,121)
Trade accounts payable		125,939	(522,200)	167,884
Deferred profit		(277,440)	163,467	604,573
Accrued expenses and other liabilities		(304,652)	(108,833)	123,462
Net cash provided by operating activities		4,652,269	5,178,938	3,099,674
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets		(396,670)	(501,568)	(546,034)
Business acquisitions, net of cash acquired		0	(119,955)	0
Purchases of available-for-sale securities		0	0	(567,819)
Proceeds from maturities of available-for-sale securities		34,336	91,295	190,269
Proceeds from sales of available-for-sale securities		3,430	6,837	1,543,434
Other, net		(11,710)	(11,171)	(7,575)
Net cash (used for) provided by investing activities		(370,614)	(534,562)	612,275
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs		(256,104)	(23,206)	(11,889)
Treasury stock purchases		(2,842,807)	(2,017,012)	(3,865,663)
Dividends paid		(1,018,915)	(907,907)	(815,290)
Reissuances of treasury stock related to employee stock purchase plan		119,966	109,899	108,178
Proceeds from issuance of common stock		15,553	11,111	5,682
Other, net		(13,543)	(3,552)	45
Net cash used for financing activities		(3,995,850)	(2,830,667)	(4,578,937)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(22,374)	128	(30,227)
Net change in cash, cash equivalents and restricted cash		263,431	1,813,837	(897,215)
Cash, cash equivalents and restricted cash at beginning of year	[1]	5,587,372	3,773,535	4,670,750
Cash, cash equivalents and restricted cash at end of year	[1]	5,850,803	5,587,372	3,773,535
Schedule of non-cash transactions
Accrued payables for stock repurchases, including applicable excise tax		51,471	45,486	46
Accrued payables for capital expenditures		60,826	31,899	80,296
Dividends payable		260,905	231,267	205,615
Transfers of finished goods inventory to property and equipment		71,267	76,856	75,068
Supplemental disclosures:
Cash payments for interest		173,094	174,745	175,528
Cash payments for income taxes, net		991,821	809,748	807,669
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents		5,847,856	5,337,056	3,522,001
Restricted cash and cash equivalents	[1]	2,947	250,316	251,534
Total cash, cash equivalents, and restricted cash	[1]	$ 5,850,803	$ 5,587,372	$ 3,773,535

[1] Restricted cash is reported within Other assets in the Consolidated Balance Sheets